Beta-adrenoblockers in cardiology practice

被引：0

作者：

Garganeeva, A. A. ^{[1
]}

机构：

[1] Russian Acad Med Sci, Cardiol Res Inst, Siberian Branch, Tomsk, Russia

来源：

CARDIOVASCULAR THERAPY AND PREVENTION | 2010年 / 9卷 / 05期

关键词：

Cardiovascular disease; beta-adrenoblockers; class effect; influence on prognosis; HEART-FAILURE; MYOCARDIAL-INFARCTION; CALCIUM-ANTAGONIST; NONCARDIAC SURGERY; HYPERTENSION; BLOCKERS; METOPROLOL; MORTALITY; BLOCKADE; ATENOLOL;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article is focused on actual and disputable points of use of beta-blockers for decrease of cardiovascular events in patients with arterial hypertension, ischemic heart disease, heart failure, diabetes mellitus and after non-cardiac surgical operations. Class of beta-blockers is very heterogeneous group of drugs which have different physical and chemical properties, various beta-receptor's selectivity and additional characteristics. That is why the popular concept of "class-effect" seems not valid for this particular pharmaceutical class. The need for independent direct comparisons of different beta-blockers in randomised controlled trials is discussed.

引用

页码：107 / 114

页数：8

共 50 条

[31] Effect of angiotensin-converting enzyme inhibitors, beta-adrenoblockers and their combinations on survival and blood plasma catecholamine levels in rats with chronic heart failure with induced exacerbations [J].

Sidorov, A. V. ;

Fateev, M. M. .

JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY, 2013, 49 (03) :330-340

[32] Perioperative Beta Blockade in Noncardiac Surgery: A Systematic Review for the 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J].

Wijeysundera, Duminda N. ;

Duncan, Dallas ;

Nkonde-Price, Chileshe ;

Virani, Salim S. ;

Washam, Jeffrey B. ;

Fleischmann, Kirsten E. ;

Fleisher, Lee A. .

CIRCULATION, 2014, 130 (24) :2246-2264

[33] Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology [J].

Agesen, Frederik N. ;

Weeke, Peter E. ;

Tfelt-Hansen, Peer ;

Tfelt-Hansen, Jacob .

PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (04)

[34] Changes in the practice of cardiology: therapies at the forefront of science [J].

Loh, Joshua Ping-Yun ;

Poh, Kian-Keong .

SINGAPORE MEDICAL JOURNAL, 2016, 57 (07) :344-346

[35] The Role of the Clinical Pharmacist in a Preventive Cardiology Practice [J].

Warden, Bruce A. ;

Shapiro, Michael D. ;

Fazio, Sergio .

ANNALS OF PHARMACOTHERAPY, 2019, 53 (12) :1214-1219

[36] Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology [J].

German, Charles A. ;

Baum, Seth J. ;

Ferdinand, Keith C. ;

Gulati, Martha ;

Polonsky, Tamar S. ;

Toth, Peter P. ;

Shapiro, Michael D. .

AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 12

[37] Carvedilol in every day cardiology and interventional cardiology practice [J].

Konyi Attila .

ORVOSI HETILAP, 2017, 158 (37) :1453-1457

[38] Erectile dysfunction in the cardiology practice-a patients' perspective [J].

Nicolai, Melianthe P. J. ;

van Bavel, Joyce ;

Somsen, G. Aernout ;

de Grooth, Greetje J. ;

Tulevski, Igor I. ;

Lorsheyd, Anouk ;

Putter, Hein ;

Schalij, Martin J. ;

Pelger, Rob C. M. ;

Elzevier, Henk W. .

AMERICAN HEART JOURNAL, 2014, 167 (02) :178-185

[39] Depression and anxiety in the practice of cardiology [J].

Dudek, Dominika ;

Jaeschke, Rafal ;

Styczen, Krzysztof ;

Pilecki, Maciej .

KARDIOLOGIA POLSKA, 2013, 71 (08) :781-786

[40] GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE [J].

Tkacheva, O. N. ;

Belenkov, Yu N. ;

Karpov, Yu A. ;

Zyryanov, S. K. .

KARDIOLOGIYA, 2019, 59 (12) :54-63

← 1 2 3 4 5 →